Methods And Compositions Of Treating Autoimmune Diseases

Abstract

Embodiments of various aspects described herein are directed to methods and compositions for producing a tolerognic or immunosuppressive dendritic cell. In particular, an immunosuppressive dendritic cell can be produced by contacting a dendritic cell with an agent that stimulates the IL 27/ectonucleotidase CD39 axis signaling. In some embodiments, the methods and/or compositions described herein can be used for treating an autoimmune disease or disorder, e.g., but not limited to multiple sclerosis (MS) and type 1 diabetes.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 1, 2019
  • Application: Apr 11, 2014
    US US 201414783679 A
  • Priority: Apr 11, 2014
    US US 201414783679 A
  • Priority: Apr 11, 2014
    US US 2014/0033872 W
  • Priority: Apr 11, 2013
    US US 201361853745 P

Download Citation


Sign in to the Lens

Feedback